Abstract
In 2012, our institution transitioned from low dose-rate (LDR) brachytherapy to high dose-rate (HDR) brachytherapy. There is a growing body of literature reporting outcomes of these two treatment techniques across different settings, although large comparative analyses are limited. We report clinical outcomes following brachytherapy for cervical cancer at our institution over a continuous 10-year period.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Paper version not known
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
